Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-25

Clinical Trial Update: Trial of Sertraline to Treat Children With Fragile X Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sertraline for children with Fragile X Syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertraline (Sertraline)

Snippet

Sponsor: Randi J. Hagerman, MD | Conditions: Fragile X Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-09-25